114 related articles for article (PubMed ID: 10537323)
1. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin.
Campbell DH; Sutherland RL; Daly RJ
Cancer Res; 1999 Oct; 59(20):5376-85. PubMed ID: 10537323
[TBL] [Abstract][Full Text] [Related]
2. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the EMS1 gene and its product, human Cortactin.
Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
[TBL] [Abstract][Full Text] [Related]
4. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines.
Campbell DH; deFazio A; Sutherland RL; Daly RJ
Int J Cancer; 1996 Nov; 68(4):485-92. PubMed ID: 8945620
[TBL] [Abstract][Full Text] [Related]
5. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
6. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.
Yang CP; Horwitz SB
Cancer Res; 2000 Sep; 60(18):5171-8. PubMed ID: 11016645
[TBL] [Abstract][Full Text] [Related]
7. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP.
Martinez-Quiles N; Ho HY; Kirschner MW; Ramesh N; Geha RS
Mol Cell Biol; 2004 Jun; 24(12):5269-80. PubMed ID: 15169891
[TBL] [Abstract][Full Text] [Related]
8. Inducible phosphorylation of cortactin is not necessary for cortactin-mediated actin polymerisation.
Illés A; Enyedi B; Tamás P; Balázs A; Bogel G; Buday L
Cell Signal; 2006 Jun; 18(6):830-40. PubMed ID: 16109479
[TBL] [Abstract][Full Text] [Related]
9. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
10. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
Hartkamp J; Troppmair J; Rapp UR
Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.
Patel AS; Schechter GL; Wasilenko WJ; Somers KD
Oncogene; 1998 Jun; 16(25):3227-32. PubMed ID: 9681820
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Leu CM; Chang C; Hu C
Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate.
Tardif M; Rabiet MJ; Christophe T; Milcent MD; Boulay F
J Immunol; 1998 Dec; 161(12):6885-95. PubMed ID: 9862721
[TBL] [Abstract][Full Text] [Related]
15. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
16. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.
Schuuring E; Verhoeven E; Litvinov S; Michalides RJ
Mol Cell Biol; 1993 May; 13(5):2891-98. PubMed ID: 8474448
[TBL] [Abstract][Full Text] [Related]
17. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.
Touyz RM; Yao G; Quinn MT; Pagano PJ; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):512-8. PubMed ID: 15618548
[TBL] [Abstract][Full Text] [Related]
18. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
Vanderkuur JA; Butch ER; Waters SB; Pessin JE; Guan KL; Carter-Su C
Endocrinology; 1997 Oct; 138(10):4301-7. PubMed ID: 9322943
[TBL] [Abstract][Full Text] [Related]
19. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhibitors of mitogen-activated protein kinase kinase on alpha(1B)-adrenoceptor phosphorylation.
Alcántara-Hernández R; Adolfo García-Sáinz J
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):13-23. PubMed ID: 19302552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
